SC
IBB icon

Solstein Capital’s iShares Biotechnology ETF IBB Stock Holding History

Solstein Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.7K Hold
330
– – 0.02% 214
2025
Q4 		$55.7K Hold
330
– – 0.02% 201
2025
Q3 		$47.6K Hold
330
– – 0.01% 209
2025
Q2 		$41.7K Hold
330
– – 0.02% 215
2025
Q1 		$42.2K Sell
330
-175
-35% -$23.7K 0.02% 152
2024
Q4 		$66.8K Hold
505
– – 0.04% 143
2024
Q3 		$73.5K Sell
505
-17
-3% -$2.46K 0.04% 139
2024
Q2 		$71.7K Hold
522
– – 0.05% 134
2024
Q1 		$71.6K Hold
522
– – 0.05% 128
2023
Q4 		$70.9K Sell
522
-58
-10% -$7.08K 0.05% 133
2023
Q3 		$70.9K Hold
580
– – 0.06% 133
2023
Q2 		$73.6K Hold
580
– – 0.06% 131
2023
Q1 		$74.9K Hold
580
– – 0.07% 129
2022
Q4 		$76.1K Hold
580
– – 0.06% 141
2022
Q3 		$68K Hold
580
– – 0.06% 136
2022
Q2 		$68K Sell
580
-43
-7% -$5.1K 0.05% 156
2022
Q1 		$81K Hold
623
– – 0.05% 161
2021
Q4 		$95K Hold
623
– – 0.06% 167
2021
Q3 		$101K Buy
623
+43
+7% +$7.24K 0.06% 172
2021
Q2 		$95K Buy
+580
New +$89.3K 0.12% 163
2020
Q4 		– Sell
-1,245
Closed -$169K – 144
2020
Q3 		$169K Hold
1,245
– – 0.38% 64
2020
Q2 		$171K Hold
1,245
– – 0.41% 56
2020
Q1 		$134K Sell
1,245
-1,150
-48% -$132K 0.52% 38
2019
Q4 		$289K Buy
+2,395
New +$267K 0.58% 40
2019
Q3 		– Sell
-2,480
Closed -$271K – 33
2019
Q2 		$271K Buy
2,480
+1,240
+100% +$132K 1.74% 18
2019
Q1 		$139K Buy
+1,240
New +$136K 0.78% 34

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Solstein Capital's IBB Position: Q1 2026 in Review

Solstein Capital held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 330 shares worth $55.7K. The position accounts for 0.02% of the portfolio, ranked #214.

Solstein Capital first reported a position in IBB in Q1 2019 and has held it in 26 quarters since. The position peaked at $289K in Q4 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Solstein Capital held 330 shares of iShares Biotechnology ETF worth $55.7K as of Q1 2026.
  • Solstein Capital left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.02% of Solstein Capital's portfolio in Q1 2026, its #214 holding.
  • Solstein Capital first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 26 quarters since.
  • Solstein Capital's iShares Biotechnology ETF position peaked at $289K in Q4 2019.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.